Ameriprise’s Ardent Health ARDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$20.8M Buy
2,110,599
+333,873
+19% +$3.17M ﹤0.01% 1505
2026
Q1
$15.2M Buy
1,776,726
+655,169
+58% +$5.88M ﹤0.01% 1601
2025
Q4
$9.9M Sell
1,121,557
-647,778
-37% -$7.49M ﹤0.01% 1917
2025
Q3
$23.4M Buy
1,769,335
+134,513
+8% +$1.68M 0.01% 1280
2025
Q2
$22.3M Buy
1,634,822
+703,739
+76% +$9.47M 0.01% 1275
2025
Q1
$12.8M Buy
+931,083
New +$13.6M ﹤0.01% 1584

Other funds holding ARDT

Ameriprise's ARDT Position: Q2 2026 in Review

Ameriprise increased its Ardent Health (ARDT) stake by 19% in Q2 2026, buying an estimated $3.17M and bringing the position to 2,110,599 shares worth $20.8M. The position accounts for ﹤0.01% of the portfolio, ranked #1505.

Ameriprise first reported a position in ARDT in Q1 2025 and has held it in 6 quarters since. The position peaked at $23.4M in Q3 2025. 139 funds tracked by Wall St. Rank hold ARDT as of Q2 2026.

  • Ameriprise held 2,110,599 shares of Ardent Health worth $20.8M as of Q2 2026.
  • Ameriprise bought 333,873 Ardent Health shares in Q2 2026, an estimated $3.17M.
  • Ardent Health made up ﹤0.01% of Ameriprise's portfolio in Q2 2026, its #1505 holding.
  • Ameriprise first reported a position in Ardent Health in Q1 2025 and has held it in 6 quarters since.
  • Ameriprise's Ardent Health position peaked at $23.4M in Q3 2025.
  • 139 funds tracked by Wall St. Rank held Ardent Health as of Q2 2026.

Based on Ameriprise's 13F filing for Q2 2026, filed 14 Aug 2026.